Comparing the current results to its competitors, Onemednet reported Revenue increase in the 2 quarter 2026 by 0 % year on year. The revenue growth was below Onemednet's competitors' average revenue growth of 5.33 %, achieved in the same quarter.
June 14, 2024
In a year marked by rapid advancements in life sciences, OneMedNet Corporation (Nasdaq: ONMD) is making waves with a series of strategic moves that could redefine the landscape of Real World Data (RWD) utilization in clinical trials. The company s recent announcements highlight a significant partnership, unprecedented network expansion, and resounding reception at a prominent industry summit each element reinforcing OneMedNet s position as a leading curator of regulatory-grade RWD. A Strategic Alignment with a Leading Clinical Trial Design CompanyOneMedNet s recent partnership with a leading clinical trial design and software company marks a pivotal moment for the organization, exemplified by a notable dat...
June 6, 2024
In an era where data-driven insights are foundational to advancing medical research and patient care, OneMedNet is making significant strides by broadening its industry footprint through collaboration with the Amazon Web Services (AWS) Partner Network. This strategic move is set to enhance the accessibility and impact of OneMedNet s innovative iRWD (integrated Real-World Data) Network and Platform, solidifying the company s position at the forefront of the healthcare data revolution. Strategic Synergy: OneMedNet and AWS OneMedNet s decision to join the AWS Partner Network comes as no surprise given the increasing demands for secure, scalable, and sophisticated data solutions within the life sciences sector. ...
May 29, 2024
OneMedNet Seals Major Deal, Set to Transform Medical Data Management The landscape of medical technology is poised for a significant shift as OneMedNet, an industry leader in integrated medical data solutions, announces a landmark agreement with a global top-10 medical technology company. This collaboration, centered around OneMedNet s innovative iRWD platform, promises to bring substantial advancements in the accessibility and utilization of Real-World Data (RWD), impacting more than 150 million patients annually. Revolutionizing Real-World Data Utilization The incorporation of Real-World Data (RWD) into clinical practice and research has been a topic of intense interest and exploration over the past decade...
February 12, 2024
OneMedNet iRWD Draws Attention at Clinical Trials MeetingMINNEAPOLIS, Feb. 12, 2024 - OneMedNet Corporation (Nasdaq: ONMD), the leading curator of regulatory-grade imaging Real World Data (iRWD), is making waves at the 15th Annual SCOPE Summit. With attendees showing a keen interest in their innovative platform, OneMedNet is setting a new standard in the field of clinical trials and real-world data collection.The 15th Annual SCOPE Summit is a prominent event in the healthcare industry, bringing together experts, researchers, and professionals from various disciplines. The conference focuses on advancing clinical trial operations, informatics, and cybersecurity, providing a platform for industry leaders to ex...
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
National Research Corporation (NRC) operates as a healthcare research and performance measurement firm, providing insights and data-driven solutions. They collect, analyze, and interpret patient and healthcare provider feedback to assist organizations in improving their overall quality of care. NRC's business model focuses on selling research products, licensing data services, and providing consulting solutions to healthcare organizations seeking to enhance patient experiences and outcomes.
Zynex Inc's business model revolves around the development and distribution of medical devices and software that provide non-invasive electrotherapy for pain management and rehabilitation.
Sources:
Onemednet Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Onemednet Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
